SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0001144204-13-013609
Filing Date
2013-03-07
Accepted
2013-03-07 16:09:47
Documents
13
Period of Report
2012-12-31

Document Format Files

Seq Description Document Type Size
1 FORM 10-K v334886_10k.htm 10-K 1179673
2 EXHIBIT 23.1 v334886_ex23-1.htm EX-23.1 6542
3 EXHIBIT 23.2 v334886_ex23-2.htm EX-23.2 2709
4 EXHIBIT 31.1 v334886_ex31-1.htm EX-31.1 10085
5 EXHIBIT 31.2 v334886_ex31-2.htm EX-31.2 10188
6 EXHIBIT 32.1 v334886_ex32-1.htm EX-32.1 4175
7 EXHIBIT 32.2 v334886_ex32-2.htm EX-32.2 4061
  Complete submission text file 0001144204-13-013609.txt   7130665

Data Files

Seq Description Document Type Size
8 XBRL INSTANCE DOCUMENT chtp-20121231.xml EX-101.INS 926408
9 XBRL TAXONOMY EXTENSION SCHEMA chtp-20121231.xsd EX-101.SCH 64028
10 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE chtp-20121231_cal.xml EX-101.CAL 32176
11 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE chtp-20121231_def.xml EX-101.DEF 264798
12 XBRL TAXONOMY EXTENSION LABEL LINKBASE chtp-20121231_lab.xml EX-101.LAB 427167
13 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE chtp-20121231_pre.xml EX-101.PRE 322883
Mailing Address 3530 TORINGDON WAY SUITE 200 CHARLOTTE NC 28277
Business Address 3530 TORINGDON WAY SUITE 200 CHARLOTTE NC 28277 704-341-1516
Chelsea Therapeutics International, Ltd. (Filer) CIK: 0001333763 (see all company filings)

IRS No.: 203174202 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-K | Act: 34 | File No.: 000-51462 | Film No.: 13673511
SIC: 2836 Biological Products, (No Diagnostic Substances)